Jiang Xinxin Medtec Co (SZSE:300453) Total Stockholders Equity : ¥1,383 Mil (As of Mar. 2025)

View and export this data going back to 2015. Start your Free Trial

What is Jiang Xinxin Medtec Co Total Stockholders Equity?

Jiang Xinxin Medtec Co's Total Stockholders Equity for the quarter that ended in Mar. 2025 was ¥1,383 Mil. It refers to the net assets owned by shareholders. It does not include minority interest.

Total Stockholders Equity is used to calculate Book Value per Share. Jiang Xinxin Medtec Co's Book Value per Share for the quarter that ended in Mar. 2025 was ¥2.65. The ratio of a company's debt over equity can be used to measure how leveraged this company is. Jiang Xinxin Medtec Co's Debt-to-Equity for the quarter that ended in Mar. 2025 was 0.16.

Jiang Xinxin Medtec Co Total Stockholders Equity Historical Data

The historical data trend for Jiang Xinxin Medtec Co's Total Stockholders Equity can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Jiang Xinxin Medtec Co Total Stockholders Equity Chart

Jiang Xinxin Medtec Co Annual Data

Trend

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Dec24

Total Stockholders Equity

Get a 7-Day Free Trial

785.20

905.51

1,076.11

1,246.43

1,324.07

Jiang Xinxin Medtec Co Quarterly Data
	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24	Jun24	Sep24	Dec24	Mar25
Total Stockholders Equity	Get a 7-Day Free Trial															1,257.72	1,234.78	1,248.44	1,324.07	1,383.08

Jiang Xinxin Medtec Co (SZSE:300453) Total Stockholders Equity Explanation

1. Total Stockholders Equity is used to calculate Book Value per Share.

Jiang Xinxin Medtec Co's Book Value per Share for the quarter that ended in Mar. 2025 is

Book Value per Share	=	(Total Stockholders Equity	-	Preferred Stock)	/	Shares Outstanding (EOP)
	=	(1383.075	-	0)	/	522.398
	=	2.65

2. The ratio of a company's debt over equity can be used to measure how leveraged this company is.

Jiang Xinxin Medtec Co's Debt-to-Equity for the quarter that ended in Mar. 2025 is

Debt-to-Equity	=	Total Debt			/	Total Stockholders Equity
	=	(Short-Term Debt & Capital Lease Obligation	+	Long-Term Debt & Capital Lease Obligation)	/	Total Stockholders Equity
	=	(40.483	+	175.079)	/	1383.075
	=	0.16

Jiang Xinxin Medtec Co Total Stockholders Equity Related Terms

Thank you for viewing the detailed overview of Jiang Xinxin Medtec Co's Total Stockholders Equity provided by GuruFocus.com. Please click on the following links to see related term pages.

Jiang Xinxin Medtec Co Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Jiang Xi Sanxin Medtec Co Ltd (SZSE:300453) » Definitions » Total Stockholders Equity

Comparable Companies

Traded in Other Exchanges

N/A

Address

No. 999, Fushan Avenue, Xiaolan Economic Development Zone, Nanchang County, Jiangxi Province, Nanchang, CHN, 330200

Website

http://www.sanxin-med.com

Jiang Xi Sanxin Medtec Co Ltd is engaged in researching and developing, manufacturing and marketing of medical devices. Its products include four series: blood purification, indwelling catheters, injections, infusion and blood transfusion. Blood purification products are used in clinical dialysis treatment for uremic patients. Indwelling catheter products represented by venous indwelling needles, positive pressure indwelling needles, central venous catheters. Injectable products mainly include self-destructing syringes, retracting self-destructing syringes, conjoined syringes.

Executives

Zhang Lin	Supervisors
Le Zhen Rong	Executives
Mao Zhi Ping	Directors, executives
Yu Zhen Zhu	Supervisors
Peng Yi Xing	Director
Liu Ming	Securities Affairs Representative
Wan Xiao Ping	Director
Wang Qin Hua	Supervisors
Xiong Yan	Supervisors

Jiang Xinxin Medtec Co Headlines

No Headlines